Traditional Chinese medicine composition for treating chronic hepatitis B

Abstract

The invention discloses a traditional Chinese medicine composition for treating chronic hepatitis B. The composition disclosed by the invention comprises the following components in parts by weight: 50 parts of silky ants, 3 parts of scorpio, 25 parts of turtle shells, 35 parts of bighead atractylodes rhizome, 45 parts of worm grass, 30 parts of the fruit of Chinese wolfberry, 5 parts of astragalus membranaceus, 20 parts of fructus schizandrae, 0.5 part of large-leaved gentian, 45 parts of grifola, 30 parts of pericarpium citri reticulatae, 30 parts of hawthorns (scorched), 30 parts of medicated leaven (scorched), 30 parts of malt (scorched), 30 parts of pericarpium citri reticulatae viride, 45 parts of nutgall, 45 parts of polygonum multiflorum, 45 parts of vitis amurensis, 45 parts of hypericum japonicum and 45 parts of Lysimachia christinae Hance. The traditional Chinese medicine composition gives full play to a special broad spectrum immune two-way regulation of the ants, and the ants are directly absorbed and utilized by a human body in form of enzyme while all active components and active substances of the ants are maintained. By taking the silky ants as a monarch drug, the composition has the functions of clearing away heat and toxic materials and combating poison with poison and seizes the characteristics of chronicle hepatitis B virus. By taking astragalus membranaceus as a ministerial drug, the composition has the functions of nourishing liver and kidney, clearing away heat and toxic materials, soothing and protecting the liver and strengthening the body resistance to eliminate pathogenic factors; the composition has the characteristics of being stable in curative effect, high in negative conversion ratio and cure rate and low in recurrence rate.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition, which belongs to medicines for treating liver diseases, in particular to a traditional Chinese medicine composition for treating chronic hepatitis B. Background technique [0002] Hepatitis B is an infectious disease. According to WHO statistics, about 240 million people worldwide suffer from chronic (long-term) liver infectious diseases, and about 780,000 people die of acute or chronic hepatitis every year. [0003] The highest prevalence of liver diseases in my country is viral hepatitis, among which hepatitis B has the highest prevalence, and the proportion of hepatitis B carriers in the national population aged 1-59 is 7%. According to incomplete statistics, there are more than 100 million people infected with hepatitis B virus and more than 20 million chronic hepatitis B patients in my country, which is a high incidence area of ​​hepatitis B. More than 80% of serious diseases su...

AI Technical Summary

Problems solved by technology

But so far, the existing viral drugs such as interferon can indirectly kill the virus while increasing the antibody, and the negative conversion rate is low, and it is easy to relapse